Lindbrook Capital’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$55.5K Buy
2,978
+188
+7% +$2.8K 0.01% 953
2024
Q4
$31.4K Buy
2,790
+14
+0.5% +$164 ﹤0.01% 1030
2024
Q3
$32.8K Hold
2,776
﹤0.01% 1017
2024
Q2
$21.7K Buy
2,776
+1,924
+226% +$12.6K ﹤0.01% 1202
2024
Q1
$4.23K Buy
852
+597
+234% +$3.82K ﹤0.01% 1966
2023
Q4
$2.2K Sell
255
-227
-47% -$1.66K ﹤0.01% 2224
2023
Q3
$3.35K Buy
482
+409
+560% +$2.47K ﹤0.01% 1940
2023
Q2
$420 Sell
73
-232
-76% -$1.5K ﹤0.01% 2545
2023
Q1
$1.94K Buy
+305
New +$2.91K ﹤0.01% 2258
2022
Q4
Sell
-108
Closed -$1K 2827
2022
Q3
$1K Buy
+108
New +$1.58K ﹤0.01% 2220

Other funds holding ALHC

Lindbrook Capital's ALHC Position: Q1 2025 in Review

Lindbrook Capital increased its Alignment Healthcare (ALHC) stake by 6.7% in Q1 2025, buying an estimated $2.8K and bringing the position to 2,978 shares worth $55.5K. The position accounts for 0.01% of the portfolio, ranked #953.

Lindbrook Capital first reported a position in ALHC in Q3 2022 and has held it in 10 quarters since. 207 funds tracked by Wall St. Rank hold ALHC as of Q1 2025.

  • Lindbrook Capital held 2,978 shares of Alignment Healthcare worth $55.5K as of Q1 2025.
  • Lindbrook Capital bought 188 Alignment Healthcare shares in Q1 2025, an estimated $2.8K.
  • Alignment Healthcare made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #953 holding.
  • Lindbrook Capital first reported a position in Alignment Healthcare in Q3 2022 and has held it in 10 quarters since.
  • 207 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.